URCC-18110CD
|
NCORP-University of Rochester Cancer Center
|
Implementing Palliative Care: Learning Collaborative vs. Technical Assistance
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-19075
|
NCORP-University of Rochester Cancer Center
|
Multi-center Randomized Controlled Phase II Trial to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-19085
|
NCORP-University of Rochester Cancer Center
|
Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-19178
|
NCORP-University of Rochester Cancer Center
|
Optimizing Functional Outcomes of Older Cancer Survivors After Chemotherapy
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-19185
|
NCORP-University of Rochester Cancer Center
|
Multicenter Randomized Controlled Trial Comparing Brief Behavioral Therapy for Cancer Related Insomnia (BBT-CI) and Healthy Eating Education Learning (HEAL)
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-21038
|
NCORP-University of Rochester Cancer Center
|
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-22053
|
NCORP-University of Rochester Cancer Center
|
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-22063
|
NCORP-University of Rochester Cancer Center
|
LOTUS-CC: Longitudinal Observational Trial to Uncover Subtypes of Cancer Cachexia
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
URCC-23086CD
|
NCORP-University of Rochester Cancer Center
|
Sexual Orientation and Gender Identity Data Collection in Community Oncology Practice
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|
UWI20-00-01
|
CP-CTNet_CLO-University of Wisconsin
|
A Phase II Trial of the Immunogenicity of a DNA Plasmid Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes from Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Participants with Early Stage Triple Negative Breast Cancer
|
Cancer Prevention and Control CIRB
|
Available to Open
|
|